 SAN DIEGO, July 20, 2021 GLOBE NEWSWIRE -- Sorrento Therapeutics, Inc. Nasdaq: SRNE, Sorrento today announced that it has formed a subsidiary company based in Mexico City, Sorrento Therapeutics Mexico Sorrento Mexico, to support the clinical development and registration of multiple COVID-19 related products Sorrento plans to develop and commercialize in Mexico and other Latin America territories. 